Data from Yale University School of Medicine Provide New Insights into Type 1 Diabetes (Real-world Evidence of Automated Insulin Delivery System Use).

A systematic review of real-world studies was conducted to assess the effectiveness of automated insulin delivery (AID) systems for individuals with type 1 diabetes. The review included 20 studies representing 171,209 individuals and found that the majority of studies demonstrated a significant improvement in glycemic outcomes with AID use. Specifically, there was a >10% change in time spent in the target range, a decrease in hemoglobin A1c (HbA1c) levels, and a reduction in glucose management indicator (GMI) levels. The findings suggest that AID is becoming the standard of care for individuals with type 1 diabetes, and it is important for individuals to be informed about these systems and have access to them. [Extracted from the article]

Copyright of Diabetes Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)